Clinical trial design for local therapies for brain metastases: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group

Minesh Mehta

Clinical trial design for local therapies for brain metastases: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group

Minesh Mehta

Herbert Wertheim Cancer Institute

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Lancet Oncology
Volume	19
State	Published - Jan 1 2018

Access to Document

ViewcontentFinal published version, 20.4 KBLicense: Unspecified

Cite this

@article{3df4538026e941048fca3bb59fc09f66,

title = "Clinical trial design for local therapies for brain metastases: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group",

author = "Minesh Mehta",

note = "Lancet Oncology (2018) 19(1):e33-e42",

year = "2018",

month = jan,

day = "1",

language = "American English",

volume = "19",

journal = "Lancet Oncology",

}

TY - JOUR

T1 - Clinical trial design for local therapies for brain metastases: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group

AU - Mehta, Minesh

N1 - Lancet Oncology (2018) 19(1):e33-e42

PY - 2018/1/1

Y1 - 2018/1/1

UR - https://scholarlycommons.baptisthealth.net/se-all-publications/2582

M3 - Article

VL - 19

JO - Lancet Oncology

JF - Lancet Oncology

ER -

Clinical trial design for local therapies for brain metastases: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group

Access to Document

Other files and links

Cite this